Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sabra Healthcare REIT ( (SBRA) ) just unveiled an announcement.
On June 30, 2025, Sabra Health Care REIT, Inc. announced that its subsidiary, Sabra Health Care Limited Partnership, will redeem all $500 million of its outstanding 5.125% Senior Notes due 2026 on July 31, 2025. This redemption will be funded by issuing a $500 million term loan, and it will cease the accrual of interest on the Notes, impacting the company’s financial operations and potentially its market positioning.
The most recent analyst rating on (SBRA) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on Sabra Healthcare REIT stock, see the SBRA Stock Forecast page.
Spark’s Take on SBRA Stock
According to Spark, TipRanks’ AI Analyst, SBRA is a Outperform.
Sabra Healthcare REIT shows strong financial performance with improving profitability and robust cash flow. Technical indicators suggest bullish momentum, although the stock’s high P/E ratio indicates it may be overvalued. Positive earnings call highlights and strategic corporate events contribute to a favorable outlook, despite some external challenges.
To see Spark’s full report on SBRA stock, click here.
More about Sabra Healthcare REIT
Sabra Health Care REIT, Inc. operates in the healthcare real estate investment trust (REIT) industry, focusing on acquiring, financing, and owning real estate properties for healthcare purposes. Its primary services include leasing properties to healthcare operators, with a market focus on skilled nursing facilities, senior housing, and hospitals.
Average Trading Volume: 2,625,062
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.34B
Learn more about SBRA stock on TipRanks’ Stock Analysis page.